Clinical Trials in Illinois

Showing 3881-3900 of 12,196 trials

Prospective, Multi-center, Single-arm Study of the Auryon Laser System for Treatment of Below-the-Knee (BTK) Arteries

NCT05284240

The Auryon Laser Atherectomy System has been cleared by the FDA to treat infrainguinal arterial disease including in-stent restenosis

Peripheral Arterial Disease

Midwest Cardiovascular Research Foundation60 participantsStarted Mar 2022

Miami Beach, Florida, United States • Davenport, Iowa, United States

COMPLETED125 miles

Analysis of Both Sex and Device Specific Factors on Outcomes in Patients with Non-Ischemic Cardiomyopathy

NCT03884608

The purpose of this registry is to prospectively assess outcomes of device-treated ventricular tachyarrhythmias and all-cause mortality in non-ischemic cardiomyopathy patients indicated for ICD or CRT-D implantation for the primary prevention of sudden cardiac death. Differences in outcomes will be evaluated by sex and by device type.

CardiomyopathiesGenderImplantable Defibrillator User

Biotronik, Inc.1,000 participantsStarted May 2019

Birmingham, Alabama, United States • Fairhope, Alabama, United States • Rancho Mirage, California, United States +46 more locations

Prospective, Multi-center, Single-arm Study of the Auryon Laser System for Treatment of Below-the-Knee (BTK) Arteries

Analysis of Both Sex and Device Specific Factors on Outcomes in Patients with Non-Ischemic Cardiomyopathy

Find Trials by Condition in Illinois

Cannabidiol (CBD) for the Treatment of Social Anxiety Disorder

The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)

FPA150 in Patients With Advanced Solid Tumors

Study of Pemetrexed + Platinum Chemotherapy With or Without Pembrolizumab (MK-3475) in Adults With Tyrosine Kinase Inhibitor- (TKI)-Resistant Epidermal Growth Factor Receptor- (EGFR)-Mutated Metastatic Non-squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-789/KEYNOTE-789)

Pegtibatinase As an Enzyme Therapy for Patients with Homocystinuria Caused by Cystathionine Beta-Synthase Deficiency (COMPOSE)

Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Older Adult Subjects With Overactive Bladder (OAB)

A Study of Lebrikizumab (LY3650150) Administered by Two Different Devices in Healthy Participants

Registry of Subjects With Drug Resistant Epilepsy and Treated With the VNS Therapy System.

VNS Prospective Neuromodulation of Immune and Gastrointestinal Systems

A Study to Compare the Efficacy and Safety of Luspatercept (ACE-536) Versus Epoetin Alfa for the Treatment of Anemia Due to IPSS-R Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Participants Who Require Red Blood Cell Transfusions and Are ESA Naïve

Long-Term Extension Trial of Tildrakizumab to Prove Its Safety in Subjects With Psoriatic Arthritis Who Have Previously Completed Study With Tildrakizumab.

A Study of BI 765128 in Patients With an Eye Condition Called Diabetic Macular Ischemia Who Have Received Laser Treatment

A Phase 1/2 Trial of SP-101 for the Treatment of Cystic Fibrosis (CF)

ME-344 and Bevacizumab in Previously Treated Metastatic Colorectal Cancer

Erlotinib, Gemcitabine and Nab-Paclitaxel in Advanced Pancreatic Cancer

Safety and Immunogenicity of RNA-based Vaccines Against SARS-CoV-2 Variants in Healthy Participants

A Unique Micro Water Jet Technology Device Versus Standard Debridement in the Treatment of Diabetic Foot

Observational Study to Assess Migraine Prediction Tool